Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $115
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stephen Baxter has maintained an Overweight rating on Tenet Healthcare (NYSE:THC) and increased the price target from $105 to $115.
March 28, 2024 | 2:55 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo has maintained an Overweight rating on Tenet Healthcare and raised the price target from $105 to $115.
The increase in price target by a reputable analyst like Stephen Baxter from Wells Fargo is a strong positive signal for Tenet Healthcare. It suggests confidence in the company's future performance and growth potential, likely leading to increased investor interest and potentially a rise in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100